Literature DB >> 12646813

Rapid hepatitis B virus-DNA decay in co-infected HIV-hepatitis B virus 'e-minus' patients with YMDD mutations after 4 weeks of tenofovir therapy.

Raffaele Bruno, Paolo Sacchi, Cristina Zocchetti, Valentina Ciappina, Massimo Puoti, Gaetano Filice.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12646813     DOI： 10.1097/00002030-200303280-00028

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  6 in total

1.  Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.

Authors:  Stephan Menne; Paul J Cote; Brent E Korba; Scott D Butler; Andrea L George; Ilia A Tochkov; William E Delaney; Shelly Xiong; John L Gerin; Bud C Tennant
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

2.  Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection.

Authors:  Stephan Menne; Scott D Butler; Andrea L George; Ilia A Tochkov; Yuao Zhu; Shelly Xiong; John L Gerin; Paul J Cote; Bud C Tennant
Journal:  Antimicrob Agents Chemother       Date:  2008-08-01       Impact factor: 5.191

Review 3.  Management of hepatitis B in patients coinfected with the human immunodeficiency virus.

Authors:  R Lessells; C Leen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-04-27       Impact factor: 3.267

4.  Management of HBV Infection in Liver Transplantation Patients.

Authors:  John M Vierling
Journal:  Int J Med Sci       Date:  2005-01-05       Impact factor: 3.738

5.  Tenofovir and its potential in the treatment of hepatitis B virus.

Authors:  Laura Reynaud; Maria Aurora Carleo; Maria Talamo; Guglielmo Borgia
Journal:  Ther Clin Risk Manag       Date:  2009-03-26       Impact factor: 2.423

6.  Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial.

Authors:  Leigh Peterson; Doug Taylor; Ronald Roddy; Ghiorghis Belai; Pamela Phillips; Kavita Nanda; Robert Grant; Edith Essie Kekawo Clarke; Anderson Sama Doh; Renee Ridzon; Howard S Jaffe; Willard Cates
Journal:  PLoS Clin Trials       Date:  2007-05-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.